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Influence of visceral and 
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ABSTRACT 
Objective: To verify the influence of visceral and subcutaneous fat, as well adipokines in bone 
mineral density (BMD) in obese adolescents. Subjects and methods: The study involved 125 
postpubertal obese adolescents (45 boys and 80 girls). Anthropometric measurements, body 
composition, visceral and subcutaneous fat, and BMD were determined. Leptin, adiponectin, 
and insulin levels also analyzed. Results: Data demonstrated a negative relationship between 
BMD with insulin resistance, visceral fat and leptin concentration; and bone mineral content 
with visceral/subcutaneous ratio. Positive association between BMD and subcutaneous fat was 
observed. Conclusions: Visceral fat and insulin resistance, as well as visceral/subcutaneous 
ratio and leptin concentration, were negative predictors of BMD in boys and girls, respectively. 
However, subcutaneous fat had a protective influence in BMD only in boys. Arq Bras Endocrinol Metab. 
2012;56(1):12-8
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RESUMO 
Objetivo: Verificar a influência da gordura visceral e subcutânea, assim como das adipocinas 
na densidade mineral óssea (DMO) em adolescentes obesos. Sujeitos e métodos: O estudo 
envolveu 125 adolescentes obesos pós-púberes. Medidas antropométricas, composição corpo-
ral, gordura visceral e subcutânea e DMO foram determinadas. Níveis de leptina, adiponectina 
e insulina foram analisados. Resultados: Os dados demonstraram associação negativa entre 
DMO com resistência insulínica, gordura visceral e concentração de leptina; e conteúdo mineral 
ósseo com a razão visceral/subcutânea. Associação positiva entre DMO e gordura subcutânea 
foi observada. Conclusões: Gordura visceral, resistência insulínica, razão visceral/subcutânea 
e concentração de leptina foram preditores negativos da DMO em meninos e meninas, respec-
tivamente. Entretanto, a gordura subcutânea demonstrou exercer influência positivamente na 
DMO somente nos meninos. Arq Bras Endocrinol Metab. 2012;56(1):12-8
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INTRODUCTION
Obesity is a worldwide epidemic with high preva-lence among citizens of European countries (1) 
and the USA, including the pediatric population. By 
2030, the percentage of obese children will double (2). 
In Brazil, recent research utilizing the WHO standard 
for obesity determined that one in every three children 
aged 5 to 9 years is overweight. In addition, 20% of 
Brazilian adolescents are overweight (3).
Due the important skeletal properties of adipocyte 
hormonal products, the impact of obesity in bone me-
tabolism is becoming a focus of attention. In this re-
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gard, controversial issues related to obesity and bone 
mass have been raised, some data suggest that the 
type of body fat distribution, especially visceral adi-
pocytes, are linked to the secretion of proinflamma-
tory cytokines that can act negatively on bone me-
tabolism (4-7). 
Moreover, it was recently demonstrated that hy-
perleptinemia was linked to the same inflammatory 
process present in obesity, while adiponectin pre-
sented opposite effects, exerting an anti-inflammato-
ry role (8). The leptin/adiponectin ratio represents 
a proinflammatory biomarker in obesity, and its re-
lationship with bone metabolism in adolescents has 
not been well explored. An imbalance between these 
adipokines may suggest an intrinsic influence in the 
development of metabolic diseases, including changes 
in bone metabolism (9).
Furthermore, in relation to bone mass, changes 
in proinflammatory cytokines cause a breakdown in 
bone metabolism and may induce a predominance 
of bone resorption, which could possible result in 
osteopenia and increased risk of fractures in obese 
women, compared with their leaner counterparts 
(10,11). However, these contributions varied ac-
cording to race (10). Indeed, data are conflicting re-
garding the association of visceral and subcutaneous 
fat in bone metabolism, with studies reporting posi-
tive, negative, or lack of association (12,13).
Thus, the present study aimed at verifying the in-
teraction of visceral and subcutaneous fat with bone 
mass, and the influence of pro-anti/inflammatory 
adipokines and gender in bone mass of obese ado-
lescents.
MATERIAL AND METHODS
Population
This study involved 125 postpubertal obese adoles-
cents (45 boys and 80 girls) between 14 and 18 ye-
ars old. Inclusion criteria were Tanner stage 5 (14), 
primary obesity, BMI greater than 30 kg/m² (BMI 
> 95th percentile). Exclusion criteria were the use of 
birth control pills, cortisone, anti-epileptic drugs, 
history of renal disease, alcohol intake, smoking, 
obesity due to secondary endocrine disorders, his-
tory of fractures and long-term supplementation of 
calcium, and/or other drugs that may affect bone 
metabolism. The study was conducted based on 
the principles of the Declaration of Helsinki, and 
was approved by the ethics committee on research 
at the Universidade Federal de São Paulo – Unifesp 
(#0135/04) Clinical Trial.gov: NCT01358773. All 
procedures were clearly explained to those respon-
sible for the volunteers, and written consent was 
obtained from the parent/legal guardian of each vo-
lunteer.
Anthropometric measurements
Each volunteer was weighted on a regular scale (Filizo-
la – Brazil) wearing light clothes and no shoes. Weight 
was recorded to nearest 0.1 kg, and height was measu-
red using a wall-mounted stadiometer (Sanny – model 
ES 2030) to the nearest 0.5 cm. After obtaining weight 
and height, body mass index (BMI) was calculated as 
the weight divided by height squared (kg/m²). Mean 
BMI (± SD) was 36.5 ± 4.6 kg/m².
Serum analysis
Blood samples were collected in the outpatient clinic 
at 8 am, after overnight fast. Leptin and adiponectin 
concentrations were measured by commercial im-
munoassays kits (eBioscience, San Diego, CA; and 
R & D Systems, Minneapolis, MN, respectively) ac-
cording to the manufacturer’s instructions. Insulin 
resistance was assessed by the homeostatic model asses-
sment (HOMA-IR). HOMA-IR was calculated using 
fasting blood glucose (FBG) and immunoreactive insu-
lin (I): [FBG (mg/dL) × I (mU/L)]/405. HOMA-IR 
data were analyzed according to reference values descri-
bed by Schwimmer and cols. (15). The coefficients of 
variation for the biochemical parameters analyzed were: 
insulin (µU/mL) 3.3%, adiponectin (µg/L) 4.5%, and 
leptin (ng/mL) 4.07%.
Measurement of visceral and subcutaneous fat
Abdominal ultrasound and measurements of visceral 
and subcutaneous adipose tissue were performed by 
the same physician, who was blind to the conditions 
of the volunteers. The examination was performed 
by a specialist in imaging diagnosis using a multifre-
quency transducer (broadband) at 3.5 MHz, which 
reduces the risk of error. The intra assay coefficient 
of variation for ultrassound (US) was 0.8%. This me-
thod was previously standardized for obese adolescents. 
Ultrasound measurement of subcutaneous fat tissue 
was defined as the distance between the skin and ex-
Bone mass in obese adolescents
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ternal face of the rectus abdominis. Visceral fat tissue 
was defined as the distance between the inner face 
of the rectus abdominis and the anterior wall of the 
aorta. The parameters were based on previous me-
thodological descriptions (16).
Bone mineral density and bone mineral composition
Determination of bone mineral content (BMC) in 
grams (g), and bone mineral density (BMD) in g/
cm², was performed per unit of bone densitometry 
by attenuation of dual-energy X-ray absorptiometry 
(DXA), using Hologic QDR 4200 (Hologic, Be-
dford, MA) with the appropriate software for bone 
assessment. Total body scan requires the volunteer 
to keep the right distance between his or her arms 
and legs according to the manufacturer’s specifica-
tions (17). To obtain statistically precise measure-
ments, 68% of the exams were repeated within 1DP 
(± 0.8% fat, 210 g ± tissue mass, ± 520 g fat mass, ± 
610 g whole body lean mass to total). 
Statistical analysis
All data were analyzed using Statistica version 7.0 
for Windows Vista. Statistical significance was set at 
α ≤ 5%. Normality of the data was verified with the 
Kolmogorov-Smirnov test. In the boys group, nonpa-
rametric variables were insulin, HOMA-IR, pelvis 
BMD, lean tissue, leptin and Lep/Adip ratio (ratio 
between leptin and adiponectin concentrations). In 
the girls group, nonparametric variables were spine 
BMD and Lep/Adip ratio. 
The other variables showed normal distribution 
in the two groups. Parametric data were expressed as 
mean ± SD, and nonparametric data were expressed 
as medians, minimum and maximum values. 
Statistical analyses were performed with the sam-
ple divided by gender, and were carried out to com-
pare the variables analyzed by Student’s t test for in-
dependent groups. Correlations were established by 
means of the Pearson test, for parametric data, and 
Spearman test, for nonparametric data. Finally, de-
pendencies between the variables were verified using 
multiple and simple linear regression analysis. 
RESULTS 
The study sample consisted of postpubertal obese ado-
lescents divided in two groups according to gender, 
matched for age, weight (kg), and body mass index 
(kg/m²). There were no significant differences between 
groups for subcutaneous fat (cm), insulin (µU/mL), 
HOMA-IR, age (years), BMI (kg/m²), total BMD (g/
cm²), lower limb BMD (g/cm²), pelvis BMD (g/cm²), 
spine BMD (g/cm²), BMD (Z-score), and total fat (%). 
Boys presented higher results for visceral fat (cm), glu-
cose (µU/mL), weight (kg), height (m), BMC (g), to-
tal fat (%), and total lean tissue (kg) compared to girls. 
Descriptive data are presented in the table 1.
Specifically for the boys group, correlation analy-
sis demonstrated a positive association between total 
BMD (g/cm²) and weight (kg) (r = 0.38, p = 0.01); 
lower limb BMD and subcutaneous fat (r = 0.37, p = 
0.00); glucose (r = 0.29, p = 0.02) and total fat (kg) (r 
= 0.34, p = 0.02); and BMD (z-score) and visceral fat 
(r = 0.31, p = 0.03), insulin (r = 0.36, p = 0.01), and 
HOMA-IR (r = 0.36, p = 0.01). A negative associa-
Table 1. Descriptive anthropometric data, body composition and 
biochemical parameters in 125 obese adolescents
Variables Boys  (n = 45)
Girls  
(n = 80)
p 
value*
Age (years) 16.04 ± 1.87 16.56 ± 1.56 0.100
Weight (kg) 105.85 ±  14.73 97.30 ±  14.63 0.002
Height (m) 1.71 ±  0.07 1.63 ±  0.07 0.000
Total fat (kg) 43.1 ±  10.8 46.4 ±  99.2 0.084
Total fat (%) 40.31 ±  6.41 48.05 ±  5.61 0.000
Lean tissue (kg) 56.4 (24 – 71)† 40.7 ±  14.2  0.015
Visceral fat (cm) 4.93 ±  1.58 4.18 ±  1.40 0.007
Subcutaneous fat (cm) 3.38 ±  0.82 3.69 ±  0.92 0.061
Visc/Subc ratio 1.49 ±  0.44  1.19 ± 0.50 0.001
BMI (kg/m²) 36.26 ±  4.40 36.57 ±  4.76 0.716
Glucose (µU/mL) 5.21 ±  0.47 5.00 ±  0.36 0.007
Insulin (µU/mL) 19 (4.90 - 60.3)† 17.26 ±  6.97 0.296
HOMA-IR 3.89 (0.97 - 16.1)† 3.85 ±  1.62 0.129
Adiponectin (µg/L) 7.39 ± 3.11 7.86  ±  3.41 0.67
Leptin (ng/mL) 23.57 (1.23 - 97.44)†  36.3 (1.15 - 100)† 0.03
Lep/Adip ratio 3.35 (0.15 - 21.9)†  3.91 (0.17 - 38.9)† 0.09
Total BMD (g/cm²) 1.24 ±  0.14 1.23 ±  0.09 0.743
Lower limb BMD (g/cm²) 1.32 ±  0.25 1.30 ±  0.10 0.632
Pelvis BMD (g/cm²) (0.92 – 1.01)† 1.28 ±  0.11 0.177
Spine BMD (g/cm²) 1.06 ±  0.17 1.23 (0.78 - 9.14)† 0.209
Total BMD (Z-score) 1.2 ±  1.17 1.4 ±  1.08 0.296
Total BMC (g) 2981 ±  518 2641 ±  574 0.001
 * Statistical significance set at p < 0.05; † nonparametric data described as median and minimum 
and maximum values. BMI: body mass index; BMC: bone mineral content; BMD: bone mineral 
density; HOMA-IR: insulin resistance index; Visc/Subc ratio: ratio between visceral and 
subcutaneous fat; Adip/Lep ratio: ratio between adiponectin and leptin concentration.
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Table 2. Data from correlation analysis
  Variables rvalue
p
value
Boys (n = 45)
Total BMD (g/cm²) Weight (kg) 0.38 0.01
Lower limb BMD (g/cm²) Subcutaneous fat (cm) 0.37 0.00
Glucose (µU/mL) 0.29 0.02
Total fat (kg) 0.34 0.02
Pelvis BMD (g/cm²) Total fat (kg) -0.40 0.01
BMD (Z-score) Visceral fat (cm) 0.31 0.03
Insulin (µU/ml) 0.36 0.01
HOMA-IR 0.36 0.01
Girls (n = 80)
Spine BMD (g/cm²) Leptin (ng/mL) -0.30 0.02
Total BMC (g) Visc/subc ratio -0.22 0.04
Total BMD (g/cm²) Height (m) 0.37 0.03
BMD (Z-score) Subcutaneous fat (cm) 0.29 0.00
Weight (kg) 0.39 0.00
Visc/subc ratio -0.29 0.00
Statistical significance set at p < 0.05; BMC: bone mineral content; BMD: bone mineral density.
tion was observed between pelvis BMD and total fat 
(%) (r = -0.40, p = 0.01). In the girls group, negative 
associations were found between spine BMD and leptin 
(r = -0.30, p = 0.03); visc/subc ratio (ratio between 
visceral and subcutaneous fat) and BMC (r = -0.22, 
p = 0.04); and BMD (z-score) and visc/subc ratio (r 
= -0.29, p = 0.00). Furthermore, a positive association 
was found between total BMD and height (r = 0.37, 
p = 0.03); and between BMD (z-score), subcutaneous 
fat (r = 0.29, p = 0.00) and weight (r = 0.39, p = 0.00) 
(Table 2).
Figure 1. Simple linear regression adjusted for (a)insulin (µU/mL) r² = -0.35, p = 0.01, and (b)HOMA-IR r² = -0.34, p = 0.01 for data on bone mineral density 
in the spine of boys.
Figure 2. Simple linear regression adjusted for visceral fat (cm) for data on 
bone mineral density in the spine of boys: r² = -0.31, p = 0.03.
Figure 3. Simple linear regression adjusted for visc/subc ratio for data on 
bone mineral content in girls: r² = -0.22, p = 0.04.
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Simple linear regression showed that some variables 
can be considered predictors of reduced spine BMD in 
boys. These variables were insulin (µU/mL) r² = -0.35, 
p = 0.01; HOMA-IR r² = -0.34, p = 0.01 (Figure 1 
A-B); and visceral fat r² = -0.31, p = 0.03 (Figure 2). 
In the girls group, the visc/subc ratio was a negative 
predictor of BMC r² = -0.22, p = 0.04 (Figure 3). 
DISCUSSION
It is well-established in the literature that fat deposition 
in regional, visceral or subcutaneous compartments is 
related to the development of some diseases (18,19). In 
a recent trial with adolescent students, high prevalence 
of central obesity and hypertension was observed. Cen-
tral obesity was more frequent in those aged 18 to 20 
years, in smokers, and in those that drank alcohol (20). 
One of the most important findings of the present 
study was that bone mineral density of lower limbs 
correlated positively with subcutaneous fat; and that 
visceral fat was a negative predictor of spine and to-
tal bone mineral density (g/cm² and Z-score), only in 
boys. In the girls group, bone mineral density (z-score) 
was positively associated with subcutaneous fat, and 
negatively correlated with the visc/subc ratio.
Others studies in adults have found that visceral and 
subcutaneous fat have opposite effects on bone struc-
ture. They support the hypothesis that visceral fat plays 
a pathogenic role, whereas subcutaneous fat is benefi-
cial to peak bone mass (12,21,22). 
Moreover, several factors may be important con-
tributors to bone mineral density during childhood 
and adolescence. These factors include gender, ge-
netic inheritance and changes in body dimensions 
throughout the child’s life, height, physical activity, 
calcium intake, hormonal status, and subcutaneous 
and visceral fat accumulation (23,24). 
It is known that obesity causes a complete change 
in hormonal and adipokine profile, resulting in altered 
bone mass (9). In agreement with previous findings, 
the present investigation showed that visceral fat de-
position and visceral/subcutaneous ratio were negative 
predictive factors for bone mineral density in the pa-
tients analyzed. 
In fact, previous studies of our group showed that 
visceral fat greater than 5.53 cm for boys and 4.5 cm 
for for girls was a predictive risk factor for Nonalcoholic 
Fatty Liver Disease (NAFLD), an emerging risk factor 
in metabolic syndrome (24,25). However, we did not 
investigate the association between NAFLD and bone 
health in the present study. Together, these results 
suggest an intrinsic role between visceral fat and the 
develop ment of bone metabolic diseases in the young 
obese patients (Table 1, Figures 2 and 3). This hypoth-
esis needs to be confirmed by future investigations. 
Moreover, secretions from visceral adipose tissue are 
directly related with the development of insulin resis-
tance and type 2 diabetes (18). In contrast, subcuta-
neous fat seems to have a protective influence, preven-
ting the onset of atherosclerosis, which corroborate our 
findings on the role of fat deposition on bone mineral 
density in both boys and girls (Table 2).
Another relevant finding observed in the present 
study was that increased insulin concentration and 
HOMA-IR were considered negative predictors of 
spine bone mineral density in boys. It is known that 
insulin induces osteoblast proliferation and collagen 
production; however, its action is not fully elucidated 
in patients with signs of insulin resistance (9,26-29). 
It is important to note that in our research, both 
boys and girls were insulin-resistant in the same period 
of adolescence, as demonstrated in table 1, reinforcing 
the influence of insulin homeostasis in the etiology of 
bone diseases. The role of the insulin resistance still is 
quite controversial in the literature (30-32). One im-
portant issue that needs to be explored is that the as-
sociation observed in the present investigation was only 
confirmed in boys. As a partial explanation for this dis-
crepancy between genders, we hypothesized that obese 
boys showed more pronounced visceral fat compared 
with girls. However, this hypothesis needs to be con-
firmed with a larger sample size. 
Furthermore, studies have found that obese adoles-
cents presented the framework for metabolic syndrome 
associated with the presence of insulin resistance and 
visceral fat (24,33). In addition, hyperinsulinemia is 
associated with impaired function of the IGF-1 axis, 
which is involved in determining bone thickness and 
length, density and architecture of the mature skeleton 
(34). IGF-1 axis impairment would result in low bone 
mineral density observed in children, adolescents and 
adults (28,35).
Interestingly, correlation analysis with that leptin 
concentration was a negative predictor of bone mine-
ral density in obese girls. It is important to note that 
hyperleptinemic state was found in the analyzed group, 
suggesting that leptin deficiency and/or resistance, as 
well as other proinflammatory adipokines involved in 
Bone mass in obese adolescents
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bone resorption may promote osteoporosis (22). Cor-
roborating our findings, another study reported that 
both abdominal adipose tissue and leptin were nega-
tively associated with BMC in Latino overweight chil-
dren of both genders (36).
However, these findings need to be confirmed in 
future studies, since a review of the literature did not 
show an association between leptin and bone mass in 
children and adolescents. However, in postmenopausal 
women, leptin showed to be a present a predictor of 
bone mass, and this association was not confirmed in 
a state of hyperleptinemia. Altogether, the action of 
leptin on the bones appears to be complex, and both 
positive and negative effects have been reported. It ap-
pears that leptin action may depend on their location of 
action, differentiating the effects central of peripheral. 
(37-39). 
In addition, recent review showed that excessive 
leptin secretion and/or decreased production of adi-
ponectin in obesity may either directly affect bone for-
mation or indirectly affect bone resorption through an 
up-regulated proinflammatory cytokine production. In 
fact, adiponectin was associated with a protective effect 
against osteoporosis development (26,39). However, 
the concentration of this anti-inflammatory adipokine 
was reduced in obese adolescents and adults (40), 
which may partially explain why we were not able to 
show a protective role of adiponectin in bone mineral 
density in the obese adolescents in a state of hyperlep-
tinemia (Table 1). Moreover, both osteoblasts (bone-
forming cells) and adipocytes (energy-storing cells) are 
derived from a common mesenchymal stem cell, and 
agents that inhibit adipogenesis stimulate osteoblast 
differentiation and vice-versa, those inhibiting osteo-
blastogenesis increase adipogenesis. This mechanisms 
may contribute to the influence of obesity in bone me-
tabolism (39).
Finally, the lack of a control group, of normal 
weight, represents a limitation of the present study. 
Further investigations that include a control group are 
needed. This study demonstrated that visceral fat and 
insulin resistance, as well as visceral/subcutaneous ratio 
and leptin concentration, were negative independent 
predictors of bone mineral density in boys and girls, 
respectively. However, subcutaneous fat had a protec-
tive influence in bone mineral density only in boys. Fur-
ther exploration of the protective role of adiponectin 
in bone mineral density is needed to improve clinical 
practice.
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